We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
226
Weyerhaeuser
WY
$18.5B
$401K ﹤0.01%
+16,918
New +$391K
FAST icon
227
Fastenal
FAST
$58.8B
$389K ﹤0.01%
+9,697
New +$408K
AEO icon
228
American Eagle Outfitters
AEO
$2.99B
$388K ﹤0.01%
+14,731
New +$291K
CVX icon
229
Chevron
CVX
$367B
$386K ﹤0.01%
+2,531
New +$385K
BE icon
230
Bloom Energy
BE
$64.9B
$382K ﹤0.01%
+4,391
New +$461K
GOLF icon
231
Acushnet Holdings
GOLF
$5.55B
$375K ﹤0.01%
4,700
-553
-11% -$44.9K
CDW icon
232
CDW
CDW
$17.2B
$374K ﹤0.01%
+2,746
New +$405K
SCI icon
233
Service Corp International
SCI
$11.6B
$361K ﹤0.01%
+4,624
New +$370K
SYK icon
234
Stryker
SYK
$130B
$351K ﹤0.01%
+1,000
New +$364K
UAL icon
235
United Airlines
UAL
$41.7B
$351K ﹤0.01%
3,138
+866
+38% +$87.5K
REVB icon
236
Revelation Biosciences
REVB
$4.34M
$347K ﹤0.01%
108,568
+88,568
+443% +$388K
FISV
237
Fiserv Inc
FISV
$27.7B
$340K ﹤0.01%
+5,067
New +$424K
AXS icon
238
AXIS Capital
AXS
$7.52B
$339K ﹤0.01%
+3,169
New +$315K
CRBG icon
239
Corebridge Financial
CRBG
$15.1B
$327K ﹤0.01%
10,853
+1,868
+21% +$57.4K
BLCO icon
240
Bausch + Lomb
BLCO
$5.91B
$324K ﹤0.01%
+18,944
New +$300K
DINO icon
241
HF Sinclair
DINO
$14.7B
$322K ﹤0.01%
+6,980
New +$360K
HRB icon
242
H&R Block
HRB
$5.89B
$316K ﹤0.01%
7,245
-7,261
-50% -$339K
CLBT icon
243
Cellebrite
CLBT
$3.87B
$302K ﹤0.01%
+16,759
New +$301K
IFS icon
244
Intercorp Financial Services
IFS
$6.44B
$301K ﹤0.01%
+7,117
New +$293K
MCHB
245
Mechanics Bancorp
MCHB
$3.68B
$301K ﹤0.01%
+20,606
New +$286K
DBX icon
246
Dropbox
DBX
$8.18B
$301K ﹤0.01%
10,817
+1,244
+13% +$36.2K
BXSL icon
247
Blackstone Secured Lending
BXSL
$5.7B
$300K ﹤0.01%
+11,412
New +$306K
CDTX
248
DELISTED
Cidara Therapeutics
CDTX
$300K ﹤0.01%
+1,359
New +$220K
OBDC icon
249
Blue Owl Capital
OBDC
$5.72B
$300K ﹤0.01%
24,146
-1,951
-7% -$24.8K
RNAM
250
DELISTED
Avidity Biosciences
RNAM
$300K ﹤0.01%
+4,159
New +$269K
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.